Rebeccamycin Terminated Phase 2 Trials for Gallbladder Cancer / Liver Cancer / Extrahepatic Bile Duct Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00005997Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer